This trial is testing whether adding a certain medication to a common pain-relieving treatment for shoulder surgery results in less pain, fewer narcotics needed, and higher satisfaction for patients.
1 Primary · 5 Secondary · Reporting Duration: Preoperatively (up to 30 days before surgery) and postoperatively (at 4 weeks), and change from preoperatively to postoperatively
150 Total Participants · 2 Treatment Groups
Primary Treatment: Liposomal bupivacaine · No Placebo Group · Phase 4
Age 50 - 85 · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: